EMD-14868
VelcroVax tandem HBcAg with SUMO-Affimer inserted at MIR (T=3* VLP)
EMD-14868
Single-particle3.6 Å
Deposition: 29/04/2022Map released: 18/01/2023
Last modified: 09/10/2024
Sample Organism:
synthetic construct
Sample: T=3* virus-like particle for VelcroVax tandem HBcAg with SUMO-Affimer inserted at MIR
Fitted models: 7zqa
Deposition Authors: Kingston NJ
,
Grehan K ,
Snowden JS ,
Alzahrani J,
Ranson NA ,
Rowlands DJ ,
Stonehouse NJ
Sample: T=3* virus-like particle for VelcroVax tandem HBcAg with SUMO-Affimer inserted at MIR
Fitted models: 7zqa
Deposition Authors: Kingston NJ
,
Grehan K ,
Snowden JS ,
Alzahrani J,
Ranson NA ,
Rowlands DJ ,
Stonehouse NJ
VelcroVax: a "Bolt-On" Vaccine Platform for Glycoprotein Display.
Kingston NJ ,
Grehan K ,
Snowden JS ,
Hassall M,
Alzahrani J,
Paesen GC,
Sherry L ,
Hayward C ,
Roe A,
Stephen S,
Tomlinson D,
Zeltina A,
Doores KJ ,
Ranson NA ,
Stacey M ,
Page M,
Rose NJ ,
Bowden TA ,
Rowlands DJ ,
Stonehouse NJ
(2023) mSphere , 8 , e0056822 - e0056822
,
Grehan K ,
Snowden JS ,
Hassall M,
Alzahrani J,
Paesen GC,
Sherry L ,
Hayward C ,
Roe A,
Stephen S,
Tomlinson D,
Zeltina A,
Doores KJ ,
Ranson NA ,
Stacey M ,
Page M,
Rose NJ ,
Bowden TA ,
Rowlands DJ ,
Stonehouse NJ
(2023) mSphere , 8 , e0056822 - e0056822
Grant Support:
- Medical Research Council (MRC, United Kingdom): MR/P022626/1 (United Kingdom)
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): R01 AI 169457-0 (United States)
- Wellcome Trust: 204825/Z/16/Z (United Kingdom)
- Wellcome Trust: 102174/B/13/Z (United Kingdom)